RNA interference-based nanosystems for inflammatory bowel disease therapy

References

• BaumgartDCSandbornWJCrohn’s diseaseThe Lancet2012380985315901605
   PubMed Web of Science ®Google Scholar
• TalleyNJAbreuMTAchkarJPAn evidence-based systematic review on medical therapies for inflammatory bowel diseaseAm J Gastroenterol2011106Suppl 1S2S2521472012
   PubMed Web of Science ®Google Scholar
• KaplanGGThe global burden of IBD: from 2015 to 2025Nat Rev Gastroenterol Hepatol2015121272072726323879
   PubMed Web of Science ®Google Scholar
• NgSCEmerging leadership lecture: inflammatory bowel disease in Asia: emergence of a “Western” diseaseJ Gastroenterol Hepatol201530344044525469874
   PubMedGoogle Scholar
• SinghDSrivastavaSPradhanMKanwarJRSinghMRInflammatory bowel disease: pathogenesis, causative factors, issues, drug treatment strategies, and delivery approachesCrit Rev Ther Drug Carrier Syst201532318121426080808
   PubMedGoogle Scholar
• van der HaveMMangenMJvan der ValkMEEffect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the futureInflamm Bowel Dis201420463764524518606
   PubMed Web of Science ®Google Scholar
• KappelmanMDRifas-ShimanSLPorterCQDirect health care costs of Crohn’s disease and ulcerative colitis in US children and adultsGastroenterology200813561907191318854185
   PubMed Web of Science ®Google Scholar
• TriantafillidisJKMerikasEGeorgopoulosFCurrent and emerging drugs for the treatment of inflammatory bowel diseaseDrug Des Devel Ther20115185210
   PubMed Web of Science ®Google Scholar
• OlesenMTBallarin-GonzalezBHowardKAThe application of RNAi-based treatments for inflammatory bowel diseaseDrug Deliv Transl Res20144141825786614
   PubMedGoogle Scholar
• MagroFPortelaFManagement of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapiesBioDrugs201024suppl 131421175228
   PubMed Web of Science ®Google Scholar
• ZamorePDTuschlTSharpPABartelDPRNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervalsCell20001011253310778853
   PubMed Web of Science ®Google Scholar
• GregoryRIChendrimadaTPCoochNShiekhattarRHuman RISC couples microRNA biogenesis and posttranscriptional gene silencingCell2005123463164016271387
   PubMed Web of Science ®Google Scholar
• PiatekMJWernerAEndogenous siRNAs: regulators of internal affairsBiochem Soc Trans20144241174117925110021
   PubMedGoogle Scholar
• KimDHBehlkeMARoseSDChangMSChoiSRossiJJSynthetic dsRNA Dicer substrates enhance RNAi potency and efficacyNat Biotechnol200523222222615619617
   PubMed Web of Science ®Google Scholar
• BehlkeMAProgress towards in vivo use of siRNAsMol Ther200613464467016481219
   PubMed Web of Science ®Google Scholar
• KriegelCAttarwalaHAmijiMMulti-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tractAdv Drug Deliv Rev201365689190123220324
   PubMedGoogle Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• AkhtarSBenterIFNonviral delivery of synthetic siRNAs in vivoJ Clin Invest2007117123623363218060020
   PubMed Web of Science ®Google Scholar
• ChiuYLRanaTMsiRNA function in RNAi: a chemical modification analysisRNA2003991034104812923253
   PubMed Web of Science ®Google Scholar
• ChapmanCGPekowJThe emerging role of miRNAs in inflammatory bowel disease: a reviewTherap Adv Gastroenterol201581422
   PubMed Web of Science ®Google Scholar
• LennoxKABehlkeMAChemical modification and design of anti-miRNA oligonucleotidesGene Ther201118121111112021753793
   PubMed Web of Science ®Google Scholar
• KimWJKimSWEfficient siRNA delivery with non-viral polymeric vehiclesPharm Res200926365766619015957
   PubMed Web of Science ®Google Scholar
• JacksonALBurchardJLeakeDPosition-specific chemical modification of siRNAs reduces “off-target” transcript silencingRNA20061271197120516682562
   PubMed Web of Science ®Google Scholar
• KayMAGloriosoJCNaldiniLViral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeuticsNat Med200171334011135613
   PubMed Web of Science ®Google Scholar
• BeloquiACocoRAlhouayekMBudesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitisInt J Pharm2013454277578323694806
   PubMedGoogle Scholar
• TalaeiFAtyabiFAzhdarzadehMDinarvandRSaadatzadehAOvercoming therapeutic obstacles in inflammatory bowel diseases: a comprehensive review on novel drug delivery strategiesEur J Pharm Sci201349471272223665411
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• MyersKJMurthySFlaniganAAntisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitisJ Pharmacol Exp Ther2003304141142412490618
   PubMedGoogle Scholar
• ZhangYCristofaroPSilbermannREngineering mucosal RNA interference in vivoMol Ther200614333634216766229
   PubMed Web of Science ®Google Scholar
• PeerDParkEJMorishitaYCarmanCVShimaokaMSystemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory targetScience2008319586362763018239128
   PubMed Web of Science ®Google Scholar
• PeerDFlorentinAMargalitRHyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomesBiochim Biophys Acta200316121768212729932
   PubMedGoogle Scholar
• ZhengXVladauCZhangXA novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulationBlood2009113122646265419164600
   PubMedGoogle Scholar
• XueHYGuoPWenWCWongHLLipid-based nanocarriers for RNA deliveryCurr Pharm Des201521223140314726027572
   PubMed Web of Science ®Google Scholar
• HuaSOrally administered liposomal formulations for colon targeted drug deliveryFront Pharmacol2014513824959147
   PubMedGoogle Scholar
• MizrahySPeerDPolysaccharides as building blocks for nanotherapeuticsChem Soc Rev20124172623264022085917
   PubMedGoogle Scholar
• RaemdonckKMartensTFBraeckmansKDemeesterJDe SmedtSCPolysaccharide-based nucleic acid nanoformulationsAdv Drug Deliv Rev20136591123114723680381
   PubMed Web of Science ®Google Scholar
• LeeJWParkJHRobinsonJRBioadhesive-based dosage forms: the next generationJ Pharm Sci200089785086610861586
   PubMed Web of Science ®Google Scholar
• ChourasiaMKJainSKPolysaccharides for colon targeted drug deliveryDrug Deliv200411212914815200012
   PubMed Web of Science ®Google Scholar
• van der LubbenIMVerhoefJCBorchardGJungingerHEChitosan and its derivatives in mucosal drug and vaccine deliveryEur J Pharm Sci200114320120711576824
   PubMed Web of Science ®Google Scholar
• RudzinskiWEAminabhaviTMChitosan as a carrier for targeted delivery of small interfering RNAInt J Pharm20103991–211120732398
   PubMed Web of Science ®Google Scholar
• XiaoBLarouiHViennoisENanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in miceGastroenterology2014146512891300e1281e121924503126
   PubMed Web of Science ®Google Scholar
• WangYYLaiSKSukJSPaceAConeRHanesJAddressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrierAngew Chem Int Ed Engl200847509726972918979480
   PubMed Web of Science ®Google Scholar
• KeanTRothSThanouMTrimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiencyJ Control Release2005103364365315820411
   PubMed Web of Science ®Google Scholar
• MaoHQRoyKTroung-LeVLChitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiencyJ Control Release200170339942111182210
   PubMed Web of Science ®Google Scholar
• DehousseVGarbackiNJaspartSComparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitroInt J Biol Macromol201046334234920096725
   PubMedGoogle Scholar
• ZhangJTangCYinCGalactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophagesBiomaterials201334143667367723419643
   PubMed Web of Science ®Google Scholar
• WangXZhengCWuZChitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulinJ Biomed Mater Res B Appl Biomater200988115016118618466
   PubMedGoogle Scholar
• Palmeira-de-OliveiraRPalmeira-de-OliveiraAGasparCSodium tripolyphosphate: an excipient with intrinsic in vitro anti-Candida activityInt J Pharm2011421113013421979249
   PubMedGoogle Scholar
• KatasHAlparHODevelopment and characterisation of chitosan nanoparticles for siRNA deliveryJ Control Release2006115221622516959358
   PubMed Web of Science ®Google Scholar
• SunYWanAPreparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromoleculesJ Appl Polymer Sci20071052552561
   Web of Science ®Google Scholar
• van VlietSJSaelandEvan KooykYSweet preferences of MGL: carbohydrate specificity and functionTrends Immunol2008292839018249034
   PubMedGoogle Scholar
• HeCYinLSongYTangCYinCOptimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-alpha silencing in ratsActa Biomater2015179810625662912
   PubMed Web of Science ®Google Scholar
• HeCYinLTangCYinCMultifunctional polymeric nanoparticles for oral delivery of TNF-alpha siRNA to macrophagesBiomaterials201334112843285423347838
   PubMed Web of Science ®Google Scholar
• ChuSTangCYinCEffects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticlesBiomaterials20155222923925818429
   PubMed Web of Science ®Google Scholar
• ChaturvediKGangulyKKulkarniARCyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art reviewExpert Opin Drug Deliv20118111455146821867463
   PubMed Web of Science ®Google Scholar
• DavisMEBrewsterMECyclodextrin-based pharmaceutics: past, present and futureNat Rev Drug Discov20043121023103515573101
   PubMed Web of Science ®Google Scholar
• McCarthyJO’NeillMJBourreLGene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery systemJ Control Release20131681283423500058
   PubMedGoogle Scholar
• O’MahonyAMOgierJDesgrangesSCryanJFDarcyRO’DriscollCMA click chemistry route to 2-functionalised PEGylated and cationic beta-cyclodextrins: co-formulation opportunities for siRNA deliveryOrg Biomol Chem201210254954496022614240
   PubMed Web of Science ®Google Scholar
• AouadiMTeszGJNicoloroSMOrally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationNature200945872421180118419407801
   PubMed Web of Science ®Google Scholar
• HuangZGanJJiaLAn orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel diseaseBiomaterials201548263625701029
   PubMed Web of Science ®Google Scholar
• SinghSRaySSPolylactide based nanostructured biomaterials and their applicationsJ Nanosci Nanotechnol2007782596261517685274
   PubMed Web of Science ®Google Scholar
• KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
   PubMed Web of Science ®Google Scholar
• LarouiHTheissALYanYFunctional TNFalpha gene silencing mediated by polyethyleneimine/TNFalpha siRNA nanocomplexes in inflamed colonBiomaterials20113241218122820970849
   PubMed Web of Science ®Google Scholar
• TheissALLarouiHObertoneTSNanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitisInflamm Bowel Dis20111751163117620872832
   PubMedGoogle Scholar
• GhalebAMLarouiHMerlinDYangVWGenetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-kappaB pathway inflammatory responseInflamm Bowel Dis201420581182024681655
   PubMedGoogle Scholar
• LarouiHViennoisEXiaoBFab’-bearing siRNA TNFalpha-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitisJ Control Release2014186415324810114
   PubMed Web of Science ®Google Scholar
• LibermanEATopalyVPTsofinaLMJasaitisAASkulachevVPMechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondriaNature19692225198107610785787094
   PubMed Web of Science ®Google Scholar
• LarouiHDalmassoGNguyenHTYanYSitaramanSVMerlinDDrug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse modelGastroenterology20101383843853e841e84219909746
   PubMed Web of Science ®Google Scholar
• TheissALJenkinsAKOkoroNIKlapprothJMMerlinDSitaramanSVProhibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expressionMol Biol Cell200920204412442319710421
   PubMedGoogle Scholar
• BouillotPUbrichNSommerFDucTMLoefflerJPDellacherieEProtein encapsulation in biodegradable amphiphilic microspheresInt J Pharm1999181215917210370212
   PubMedGoogle Scholar
• UskokovicVUskokovicDPNanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agentsJ Biomed Mater Res B Appl Biomater201196115219121061364
   PubMed Web of Science ®Google Scholar
• FredeANeuhausBKlopfleischRColonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivoJ Control Release2016222869626699423
   PubMed Web of Science ®Google Scholar
• SokolovaVEppleMInorganic nanoparticles as carriers of nucleic acids into cellsAngew Chem Int Ed Engl20084781382139518098258
   PubMed Web of Science ®Google Scholar
• DordelmannGKozlovaDKarczewskiSLizioRKnauerSEppleMCalcium phosphate increases the encapsulation efficiency of hydrophilic drugs (proteins, nucleic acids) into poly(d,l-lactide-co-glycolide acid) nanoparticles for intracellular deliveryJ Mat Chem B201424172507259
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPreatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• CunDFogedCYangMFrokjaerSNielsenHMPreparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA deliveryInt J Pharm20103901707519836438
   PubMedGoogle Scholar
• AliHWeigmannBCollnotEMKhanSAWindbergsMLehrCMBudesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa – pharmaceutical characterization and fluorescence imagingPharm Res20163351085109226718953
   PubMed Web of Science ®Google Scholar
• KriegelCAmijiMMDual TNF-alpha/Cyclin D1 gene silencing with an oral polymeric microparticle system as a novel strategy for the treatment of inflammatory bowel diseaseClin Transl Gastroenterol20112e223237848
   PubMedGoogle Scholar
• XiaoBMerlinDOral colon-specific therapeutic approaches toward treatment of inflammatory bowel diseaseExpert Opin Drug Deliv20129111393140723036075
   PubMed Web of Science ®Google Scholar
• BhavsarMDTiwariSBAmijiMMFormulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial designJ Control Release2006110242243016338017
   PubMed Web of Science ®Google Scholar
• KriegelCAmijiMOral TNF-alpha gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel diseaseJ Control Release20111501778620959130
   PubMed Web of Science ®Google Scholar
• RezaieAParkerRDAbdollahiMOxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?Dig Dis Sci20075292015202117404859
   PubMed Web of Science ®Google Scholar
• KruidenierLKuiperILamersCBVerspagetHWIntestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidantsJ Pathol20032011283612950014
   PubMed Web of Science ®Google Scholar
• WilsonDSDalmassoGWangLSitaramanSVMerlinDMurthyNOrally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestinesNat Mater201091192392820935658
   PubMed Web of Science ®Google Scholar
• ZhangSZhaoBJiangHWangBMaBCationic lipids and polymers mediated vectors for delivery of siRNAJ Control Release2007123111017716771
   PubMed Web of Science ®Google Scholar
• IslamMAParkTESinghBMajor degradable polycations as carriers for DNA and siRNAJ Control Release2014193748924942341
   PubMed Web of Science ®Google Scholar
• OuMXuRKimSHBullDAKimSWA family of bioreducible poly(disulfide amine)s for gene deliveryBiomaterials200930295804581419615739
   PubMed Web of Science ®Google Scholar
• BreunigMLungwitzULieblRGoepferichABreaking up the correlation between efficacy and toxicity for nonviral gene deliveryProc Natl Acad Sci U S A200710436144541445917726101
   PubMed Web of Science ®Google Scholar
• SonSNamgungRKimJSinghaKKimWJBioreducible polymers for gene silencing and deliveryAcc Chem Res20124571100111222129162
   PubMed Web of Science ®Google Scholar
• VarkouhiAKVerheulRJSchiffelersRMLammersTStormGHenninkWEGene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosanBioconjug Chem201021122339234621049986
   PubMedGoogle Scholar
• XiaoBLarouiHAyyaduraiSMannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapyBiomaterials201334307471748223820013
   PubMed Web of Science ®Google Scholar
• CoskunMBjerrumJTSeidelinJBNielsenOHMicroRNAs in inflammatory bowel disease – pathogenesis, diagnostics and therapeuticsWorld J Gastroenterol201218344629463423002331
   PubMed Web of Science ®Google Scholar
• ChenWXRenLHShiRHImplication of miRNAs for inflammatory bowel disease treatment: systematic reviewWorld J Gastrointest Pathophysiol201452637024891977
   PubMedGoogle Scholar
• ZhangYWangZGemeinhartRAProgress in microRNA deliveryJ Control Release2013172396297424075926
   PubMed Web of Science ®Google Scholar
• van RooijEKauppinenSDevelopment of microRNA therapeutics is coming of ageEMBO Mol Med20146785186424935956
   PubMed Web of Science ®Google Scholar
• PathakSGrilloARScarpaMMiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitisExp Mol Med201547e16425998827
   PubMed Web of Science ®Google Scholar
• IbrahimAFWeirauchUThomasMGrunwellerAHartmannRKAignerAMicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinomaCancer Res201171155214522421690566
   PubMed Web of Science ®Google Scholar
• SachdevaMMoYYmiR-145-mediated suppression of cell growth, invasion and metastasisAm J Transl Res20102217018020407606
   PubMed Web of Science ®Google Scholar
• ThomasMLange-GrunwellerKWeirauchUThe proto-oncogene Pim-1 is a target of miR-33aOncogene201231791892821743487
   PubMed Web of Science ®Google Scholar
• MinakuchiYTakeshitaFKosakaNAtelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivoNucleic Acids Res20043213e10915272050
   PubMed Web of Science ®Google Scholar
• OchiyaTNagaharaSSanoAItohHTeradaMBiomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicinesCurr Gene Ther200111315212109137
   PubMedGoogle Scholar
• TazawaHTsuchiyaNIzumiyaMNakagamaHTumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cellsProc Natl Acad Sci U S A200710439154721547717875987
   PubMed Web of Science ®Google Scholar
• FallingborgJChristensenLAJacobsenBARasmussenSNVery low intraluminal colonic pH in patients with active ulcerative colitisDig Dis Sci19933811198919938223071
   PubMed Web of Science ®Google Scholar
• HuaSMarksESchneiderJJKeelySAdvances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissueNanomedicine20151151117113225784453
   PubMed Web of Science ®Google Scholar
• PoutonCWSeymourLWKey issues in non-viral gene deliveryAdv Drug Deliv Rev2001461–318720311259840
   PubMed Web of Science ®Google Scholar
• DykxhoornDMPalliserDLiebermanJThe silent treatment: siRNAs as small molecule drugsGene Ther200613654155216397510
   PubMed Web of Science ®Google Scholar
• RippeBRosengrenBICarlssonOVenturoliDTransendothelial transport: the vesicle controversyJ Vasc Res200239537539012297701
   PubMedGoogle Scholar
• LamprechtAIBD: selective nanoparticle adhesion can enhance colitis therapyNat Rev Gastroenterol Hepatol20107631131220523352
   PubMed Web of Science ®Google Scholar
• DakaAPeerDRNAi-based nanomedicines for targeted personalized therapyAdv Drug Deliv Rev201264131508152122975009
   PubMed Web of Science ®Google Scholar
• FarhoodHSerbinaNHuangLThe role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transferBiochim Biophys Acta1995123522892957756337
   PubMed Web of Science ®Google Scholar
• DyawanapellySGhodkeSBVishwanathanRDandekarPJainRRNA interference-based therapeutics: molecular platforms for infectious diseasesJ Biomed Nanotechnol20141091998203725992447
   PubMed Web of Science ®Google Scholar
• XuHLiZSiJNanocarriers in gene therapy: a reviewJ Biomed Nanotechnol201410123483350726000367
   PubMed Web of Science ®Google Scholar
• SeyhanAARNAi: a potential new class of therapeutic for human genetic diseaseHum Genet2011130558360521537948
   PubMed Web of Science ®Google Scholar
• WellsCWLewisSBartonJRCorbettSEffects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patientsInflamm Bowel Dis200612212313016432377
   PubMed Web of Science ®Google Scholar
• MahajanUMTellerSSendlerMTumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancerGut Epub2016512
   Google Scholar